Here is what you need to know on Friday, July 9:
Thursday was all set to be the reversal many had been predicting. Europe was ugly, Delta is everywhere, and bond yields were dumping as stocks initially tumbled. But turnaround Thursday quickly set in as traders recognized a dip and went back to their playbooks for 2021, since buying the dip is the most profitable show in town. Friday appears to be proving the theory as European markets pop and US futures lead higher.
We still worry over the narrowness of this rally with the broad Russell 2000 index falling more than the main indices on Thursday and looking more and more like it has set a bearish triple top.
The dollar is calm at 1.1867 versus the euro. Gold is at $1,802, Bitcoin is flat at $32,850, and Oil is also steady at $74. The focus on yields has led to some correction back to 1.34% for the US 10-year yield. The VIX is also a tad lower at 17.5.
European markets are higher, Dax +1%, FTSE +0.7% and EuroStoxx +1.4%.
US futures are also higher: the Nasdaq is flat, Dow +0.85 and S&P +0.5%.
Wall Street top news
President Biden signs a new executive order aimed at increasing competition in big tech and other sectors.
LEVI reported earnings after the close on Thursday beating analyst expectations.
Stamps.com (STAMP) up 60% in premarket after it is said to be acquired by Thoma Bravo.
General Motors (GM): Wedbush starts coverage with an outperform rating.
Coupang (CPNG): CLSA starts coverage with an outperform rating.
Match Group (MTCH): RBC starts coverage with an outperform rating.
Beachbody (BODY): Baird decides to get in shape for summer as it starts the stock with an outperform rating.
SPCE: Number one on WallStreetBets on Friday.
NIO: HSBC upgrades, stock up 3% premarket.
Pfizer (PFE) BioNTech (BNTX): companies to trial booster shot to target delta variant.
Ford (F): China sales up over 20% YoY, stock up 3% premarket.
Upgrades, downgrades, premarket movers
Source: Benzinga Pro
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.